These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37370037)

  • 21. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
    Che L; Du ZB; Wang WH; Wu JS; Han T; Chen YY; Han PY; Lei Z; Chen XX; He Y; Xu L; Lin X; Lin ZN; Lin YC
    Cell Prolif; 2022 Nov; 55(11):e13304. PubMed ID: 35811356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.
    Liu XH; Lin J; Zhang SH; Zhang SM; Feitelson MA; Gao HJ; Zhu MH
    World J Gastroenterol; 2008 Mar; 14(9):1346-52. PubMed ID: 18322946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinoma.
    Wu CC; Wu DW; Lin YY; Lin PL; Lee H
    Surgery; 2018 May; 163(5):1040-1046. PubMed ID: 29475611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma.
    Yang CL; Song R; Hu JW; Huang JT; Li NN; Ni HH; Li YK; Zhang J; Lu Z; Zhou M; Wang JD; Li MJ; Zhan GH; Peng T; Yu HP; Qi LN; Wang QY; Xiang BD
    Hepatol Int; 2024 Feb; 18(1):73-90. PubMed ID: 38159218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
    Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
    Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
    Zhao Q; Li T; Qi J; Liu J; Qin C
    PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
    Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
    Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B.
    Yan P; Luo Y; Huang Z; Mou T; Yang H; Peng D; Wu Z
    BMC Gastroenterol; 2023 Nov; 23(1):390. PubMed ID: 37957550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC.
    Li S; Xia H; Wang Z; Zhang X; Song T; Li J; Xu L; Zhang N; Fan S; Li Q; Zhang Q; Ye Y; Lv J; Yue X; Lv H; Yu J; Lu W
    Hepatology; 2023 Oct; 78(4):1079-1091. PubMed ID: 37114494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
    Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Zhang Y; Yan Q; Gong L; Xu H; Liu B; Fang X; Yu D; Li L; Wei T; Wang Y; Wong CN; Lyu Z; Tang Y; Sham PC; Guan XY
    Oncogene; 2021 Feb; 40(6):1147-1161. PubMed ID: 33323975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
    Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z
    Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.